Merck, a prominent science and technology company, has entered into a Memorandum of Understanding (MOU) with ChemLex, an innovative firm based in Singapore that specializes in AI-driven automated chemical synthesis. This strategic collaboration, announced on January 20, 2026, aims to integrate automated experimentation and advanced chemistry workflows to enhance research and discovery in the life sciences and electronics sectors.
The MOU reflects a mutual commitment to accelerate advancements in these fields by combining Merck’s extensive scientific expertise with ChemLex’s cutting-edge automated chemistry platform. This partnership is designed to improve the speed, efficiency, and reproducibility of chemical research across various early discovery and development workflows within Merck’s diverse business sectors.
Under the framework established by the MOU, the two companies will explore multiple areas of cooperation. These may include automated synthesis, reaction optimization, high-throughput experimentation, and the integration of chemistry platforms. The initial phase of their collaboration will focus on identifying high-impact chemistry programs and establishing pathways for future collaborative efforts.
Marc Horn, President of Merck China, emphasized the significance of this partnership, stating, “This strategic partnership with ChemLex integrates AI and automation into our R&D operations, demonstrating Merck’s commitment to embrace digital transformation and accelerate innovation. We look forward to creating greater value for our customers through this collaboration.”
On the other side, Dr. Sean Lin, Founder and CEO of ChemLex, highlighted the capabilities of their proprietary chemical synthesis platform, which operates continuously with an AI closed-loop feedback mechanism. He expressed confidence that this collaboration will allow ChemLex to validate and optimize its technology in broader application scenarios, further enhancing the future of intelligent chemical synthesis alongside esteemed research teams.
The signing of this MOU underscores the shared interest of both organizations in scalable, data-rich experimental science. They are committed to fostering long-term partnerships that promote innovation at the intersection of chemistry and automation.
As discussions continue, both parties are eager to evaluate the next steps under the MOU framework, paving the way for groundbreaking advancements in automated chemistry and technological innovation.
